The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Selective deletion of astroglial FMRP dysregulates glutamate transporter GLT1 and contributes to fragile X syndrome phenotypes in vivo.
Open accessAbstract
UNLABELLED: How the loss of fragile X mental retardation protein (FMRP) in different brain cell types, especially in non-neuron glial cells, induces fragile X syndrome (FXS) phenotypes has just begun to be understood. In the current study, we generated inducible astrocyte-specific Fmr1 conditional knock-out mice (i-astro-Fmr1-cKO) and restoration mice (i-astro-Fmr1-cON) to study the in vivo modulation of FXS synaptic phenotypes by astroglial FMRP. We found that functional expression of glutamate transporter GLT1 is 40% decreased in i-astro-Fmr1-cKO somatosensory cortical astrocytes in vivo, which can be fully rescued by the selective re-expression of FMRP in astrocytes in i-astro-Fmr1-cON mice. Although the selective loss of astroglial FMRP only modestly increases spine density and length in cortical pyramidal neurons, selective re-expression of FMRP in astrocytes significantly attenuates abnormal spine morphology in these neurons of i-astro-Fmr1-cON mice. Moreover, we found that basal protein synthesis levels and immunoreactivity of phosphorylated S6 ribosomal protein (p-s6P) is significantly increased in i-astro-Fmr1-cKO mice, while the enhanced cortical protein synthesis observed in Fmr1 KO mice is mitigated in i-astro-Fmr1-cON mice. Furthermore, ceftriaxone-mediated upregulation of surface GLT1 expression restores functional glutamate uptake and attenuates enhanced neuronal excitability in Fmr1 KO mice. In particular, ceftriaxone significantly decreases the growth rate of abnormally accelerated body weight and completely corrects spine abnormality in Fmr1 KO mice. Together, these results show that the selective loss of astroglial FMRP contributes to cortical synaptic deficits in FXS, presumably through dysregulated astroglial glutamate transporter GLT1 and impaired glutamate uptake. These results suggest the involvement of astrocyte-mediated mechanisms in the pathogenesis of FXS. SIGNIFICANCE STATEMENT: Previous studies to understand how the loss of function of fragile X mental retardation protein (FMRP) causes fragile X syndrome (FXS) have largely focused on neurons; whether the selective loss of astroglial FMRP in vivo alters astrocyte functions and contributes to the pathogenesis of FXS remain essentially unknown. This has become a long-standing unanswered question in the fragile X field, which is also relevant to autism pathogenesis. Our current study generated astrocyte-specific Fmr1 conditional knock-out and restoration mice, and provided compelling evidence that the selective loss of astroglial FMRP contributes to cortical synaptic deficits in FXS, likely through the dysregulated astroglial glutamate transporter GLT1 expression and impaired glutamate uptake. These results demonstrate previously undescribed astrocyte-mediated mechanisms in the pathogenesis of FXS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Astrocyte-specific Fmr1 KO mouse displays reduced expression of the astrocytic glutamate transporter GLT-1, which leads to reduced astrocytic uptake of extracellular glutamate and increased cortical neuronal excitability (Higashimori et al., 2016).”
From Astrocytes in fragile X syndrome (2024) · cites this paper as Higashimori et al., 2016
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Species specific differences and differences in experimental approaches such as glutamate incubation time may explain different results in studies on astrocytic glutamate uptake (Higashimori et al., 2016; Ren et al., 2023).”
From Astrocytes in fragile X syndrome (2024) · cites this paper as Higashimori et al., 2016
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Glutamate neurotoxicity and diseases of the nervous system
Choi, D. W. (1988) · Neuron · doi:10.1016/0896-6273(88)90162-6 · Cited by 8,188
A robust and high-throughput Cre reporting and characterization system for the whole mouse brain
Madisen, L., Zwingman, T. A., Sunkin, S. M., Oh, S. W., Zariwala, H. A., Gu, H., Ng, L. L., Palmiter, R. D., Hawrylycz, M. J., Jones, A. R., et al. (2010) · Nature Neuroscience · doi:10.1038/nn.2467 · Cited by 6,907
Cahoy, J. D., Emery, B., Kaushal, A., Foo, L. C., Zamanian, J. L., Christopherson, K. S., Xing, Y., Lubischer, J. L., Krieg, P. A., Krupenko, S. A., et al. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.4178-07.2008 · Cited by 3,129
Epilepsy and Exacerbation of Brain Injury in Mice Lacking the Glutamate Transporter GLT-1
Tanaka, K., Watase, K., Manabe, T., Yamada, K., Watanabe, M., Takahashi, K., Iwama, H., Nishikawa, T., Ichihara, N., Kikuchi, T., et al. (1997) · Science · doi:10.1126/science.276.5319.1699 · Cited by 1,755
β-Lactam antibiotics offer neuroprotection by increasing glutamate transporter expression
Rothstein, J. D., Patel, S., Regan, M. R., Haenggeli, C., Huang, Y. H., Bergles, D. E., Jin, L., Dykes Hoberg, M., Vidensky, S., Chung, D. S., et al. (2005) · Nature · doi:10.1038/nature03180 · Cited by 1,518
A translational profiling approach for the molecular characterization of CNS cell types
Heiman, M., Schaefer, A., Gong, S., Peterson, J. D., Day, M., Ramsey, K. E., Suárez-Fariñas, M., Schwarz, C., Stephan, D. A., Surmeier, D. J., et al. (2008) · Cell · doi:10.1016/j.cell.2008.10.028 · Cited by 1,134
Fmr1 knockout mice: A model to study fragile X mental retardation
THEDUTCHBELGIANFRAGILEXCONSOR (1994) · Cell · doi:10.1016/0092-8674(94)90569-x · Cited by 1,108
Fragile X Syndrome: Loss of Local mRNA Regulation Alters Synaptic Development and Function
Bassell, G. J., & Warren, S. T. (2008) · Neuron · doi:10.1016/j.neuron.2008.10.004 · Cited by 1,051
Abnormal dendritic spines in fragile X knockout mice: Maturation and pruning deficits
Comery, T. A., Harris, J. B., Willems, P. J., Oostra, B. A., Irwin, S. A., Weiler, I. J., & Greenough, W. T. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.10.5401 · Cited by 1,046
Correction of Fragile X Syndrome in Mice
Dölen, G., Osterweil, E., Rao, B. S. S., Smith, G. B., Auerbach, B. D., Chattarji, S., & Bear, M. F. (2007) · Neuron · doi:10.1016/j.neuron.2007.12.001 · Cited by 979
Flagged first, then by citations
Cited by
Sorted by citations
Pajarillo, E. A. B., Rizor, A., Lee, J., Aschner, M., & Lee, E.-S. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.03.002 · Cited by 493
The interplay between neurons and glia in synapse development and plasticity
Stogsdill, J. A., & Eroğlu, Ç. (2016) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2016.09.016 · Cited by 182
The Regulation of Astrocytic Glutamate Transporters in Health and Neurodegenerative Diseases
Todd, A. C., & Hardingham, G. E. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249607 · Cited by 172
Neuron-Glia Interactions in Neurodevelopmental Disorders
Kim, Y. S., Choi, J., & Yoon, B. (2020) · Cells · doi:10.3390/cells9102176 · Cited by 154
Sensory Processing Phenotypes in Fragile X Syndrome
Rais, M., Binder, D. K., Razak, K. A., & Ethell, I. M. (2018) · ASN NEURO · doi:10.1177/1759091418801092 · Cited by 143
Of Men and Mice: Modeling the Fragile X Syndrome
Dahlhaus, R. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00041 · Cited by 133
Banerjee, A., Ifrim, M. F., Valdez‐Sinon, A. N., Raj, N., & Bassell, G. J. (2018) · Brain Research · doi:10.1016/j.brainres.2018.04.008 · Cited by 111
Xiong, Y., Chen, J., & Li, Y. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1125428 · Cited by 114
Channelopathies in fragile X syndrome
Deng, P., & Klyachko, V. A. (2021) · Nature reviews. Neuroscience · doi:10.1038/s41583-021-00445-9 · Cited by 112
Alterations in CA1 hippocampal synapses in a mouse model of fragile X syndrome
Jawaid, S., Kidd, G. J., Wang, J., Swetlik, C., Dutta, R., & Trapp, B. D. (2017) · Glia · doi:10.1002/glia.23284 · Cited by 93
Caldwell, A. L. M., Sancho, L., Deng, J., Bosworth, A., Miglietta, A., Diedrich, J. K., Shokhirev, M. N., & Allen, N. J. (2022) · Nature Neuroscience · doi:10.1038/s41593-022-01150-1 · Cited by 86
Hodges, J., Yu, X., Gilmore, A., Bennett, H. C., Tjia, M., Perna, J., Chen, C.-C., Li, X., Lu, J., & Zuo, Y. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.08.036 · Cited by 86
Liu, X., Yang, L., Shao, L.-X., He, Y., Wu, G., Bao, Y.-H., Lu, N., Gong, D., Lu, Y.-P., Cui, T.-T., et al. (2019) · The Journal of Experimental Medicine · doi:10.1084/jem.20180992 · Cited by 70
Koeppen, J., Nguyen, A. Q., Nikolakopoulou, A. M., Garcia, M. L., Hanna, S., Woodruff, S., Figueroa, Z. A., Obenaus, A., & Ethell, I. M. (2018) · Journal of Neuroscience · doi:10.1523/jneurosci.3618-17.2018 · Cited by 73
Liu, X., Ying, J., Wang, X., Zheng, Q., Zhao, T., Yoon, S., Yu, W., Yang, D., Yang, F., & Hua, F. (2021) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2021.729273 · Cited by 78
Verma, V., Paul, A., Vishwanath, A. A., Vaidya, B., & Clement, J. P. (2019) · Open Biology · doi:10.1098/rsob.180265 · Cited by 68
Foundations and implications of astrocyte heterogeneity during brain development and disease
Schober, A. L., Wicki‐Stordeur, L. E., Murai, K. K., & Swayne, L. A. (2022) · Trends in Neurosciences · doi:10.1016/j.tins.2022.06.009 · Cited by 63
Zohny, S. M., Habib, M. Z., Mohamad, M. I., Elayat, W. M., Elhossiny, R. M., El-Salam, M. F. A., Hassan, G. A. M., & Aboul‐Fotouh, S. (2023) · Neurotherapeutics · doi:10.1007/s13311-023-01360-w · Cited by 61
Umpierre, A. D., West, P. J., White, J. A., & Wilcox, K. S. (2018) · Journal of Neuroscience · doi:10.1523/jneurosci.1148-18.2018 · Cited by 59
Hattori, T., Kaji, M., Ishii, H., Jureepon, R., Takarada-Iemata, M., Minh Ta, H., Manh Le, T., Konno, A., Hirai, H., Shiraishi, Y., et al. (2017) · Glia · doi:10.1002/glia.23139 · Cited by 53
Ohta, K., Suzuki, S., Warita, K., Kaji, T., Kusaka, T., & Miki, T. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.13977 · Cited by 55
Cho, S., Muthukumar, A. K., Stork, T., Coutinho‐Budd, J., & Freeman, M. R. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1800830115 · Cited by 50
Do Astrocytes Play a Role in Intellectual Disabilities?
Cresto, N., Pillet, L., Billuart, P., & Rouach, N. (2019) · Trends in Neurosciences · doi:10.1016/j.tins.2019.05.011 · Cited by 51
Altered cortical Cytoarchitecture in the Fmr1 knockout mouse
Lee, F. H. F., Lai, T. K. Y., Su, P., & Liu, F. (2019) · Molecular Brain · doi:10.1186/s13041-019-0478-8 · Cited by 48
Bataveljic, D., Pivonkova, H., de Concini, V., Hébert, B., Ezan, P., Briault, S., Bemelmans, A.-P., Pichon, J., Menuet, A., & Rouach, N. (2024) · Nature Communications · doi:10.1038/s41467-024-47681-y · Cited by 40
Perkins, E., Clarkson, Y. L., Šuminaite, D., Lyndon, A. R., Tanaka, K., Rothstein, J. D., Skehel, P., Wyllie, D. J. A., & Jackson, M. T. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddy169 · Cited by 42
Sakers, K., Liu, Y., Llaci, L., Lee, S. M., Vasek, M. J., Rieger, M. A., Brophy, S., Tycksen, E., Lewis, R. M., Maloney, S. E., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21703-5 · Cited by 39
SNAP25 Inhibits Glioma Progression by Regulating Synapse Plasticity via GLS-Mediated Glutaminolysis
Huang, Q., Lian, C., Dong, Y., Zeng, H., Liu, B., Xu, N., He, Z., & Guo, H. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.698835 · Cited by 40
Wallingford, J., Scott, A. L., Rodrigues, K., & Doering, L. C. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00268 · Cited by 38
Kalinowska, M., van der Lei, M. B., Kitiashvili, M., Mamcarz, M., Oliveira, M. M., Longo, F., & Klann, E. (2021) · Molecular Autism · doi:10.1186/s13229-022-00509-2 · Cited by 39
The Application of Adeno-Associated Viral Vector Gene Therapy to the Treatment of Fragile X Syndrome
Hampson, D. R., Hooper, A. W. M., & Niibori, Y. (2019) · Brain Sciences · doi:10.3390/brainsci9020032 · Cited by 38
The Effect of GLT-1 Upregulation on Extracellular Glutamate Dynamics
Wilkie, C. M., Barron, J. C., Brymer, K. J., Barnes, J. R., Nafar, F., & Parsons, M. P. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.661412 · Cited by 35
SOX2 is essential for astrocyte maturation and its deletion leads to hyperactive behavior in mice
Wang, Y., Zhang, S., Lan, Z., Doan, V., Kim, B., Liu, S., Zhu, M., Hull, V. L., Rihani, S., Zhang, C., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111842 · Cited by 32
Astrocytes regulate neuronal network activity by mediating synapse remodeling
Kim, N., & Chung, W. (2022) · Neuroscience Research · doi:10.1016/j.neures.2022.09.007 · Cited by 31
Mazaré, N., Oudart, M., & Cohen‐Salmon, M. (2021) · Journal of Cell Science · doi:10.1242/jcs.251629 · Cited by 34
Blanco‐Urrejola, M., Gaminde‐Blasco, A., Gamarra, M., de la Cruz, A., Vecino, E., Alberdi, E. M., & Baleriola, J. (2021) · Cells · doi:10.3390/cells10030632 · Cited by 24
Mouse models of fragile X-related disorders
Willemsen, R., & Kooy, R. F. (2023) · Disease Models & Mechanisms · doi:10.1242/dmm.049485 · Cited by 30
Astrocyte‐mediated purinergic signaling is upregulated in a mouse model of Fragile X syndrome
Reynolds, K. E., Wong, C. R., & Scott, A. L. M. (2021) · Glia · doi:10.1002/glia.23997 · Cited by 25
FMRP-Driven Neuropathology in Autistic Spectrum Disorder and Alzheimer's disease: A Losing Game
Bleuzé, L., Triaca, V., & Borreca, A. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.699613 · Cited by 28
mGlu5-mediated signalling in developing astrocyte and the pathogenesis of autism spectrum disorders
Petrelli, F., & Bezzi, P. (2018) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2017.12.014 · Cited by 26
Men, Y., Ye, L., Risgaard, R. D., Promes, V., Zhao, X., Paukert, M., & Yang, Y. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2014080117 · Cited by 26
Self-citationPostsynaptic FMRP Regulates Synaptogenesis In Vivo in the Developing Cochlear Nucleus
Wang, X., Zorio, D. A. R., Schecterson, L. C., Lu, Y., & Wang, Y. (2018) · Journal of Neuroscience · doi:10.1523/jneurosci.0665-18.2018 · Cited by 24
Simhal, A. K., Zuo, Y., Perez, M. M., Madison, D. V., Sapiro, G., & Micheva, K. D. (2019) · Scientific Reports · doi:10.1038/s41598-019-50240-x · Cited by 24
Astrocyte-mediated disruption of ROS homeostasis in Fragile X mouse model
Vandenberg, G. G., Dawson, N. J., Head, A., Scott, G. R., & Scott, A. L. M. (2021) · Neurochemistry International · doi:10.1016/j.neuint.2021.105036 · Cited by 23
Astroglial FMRP modulates synaptic signaling and behavior phenotypes in FXS mouse model
Jin, S., Higashimori, H., Schin, C., Orrego, A. T., Men, Y., Chiang, M. S. R., Jarvis, R., Cox, D., Feig, L. A., & Yang, Y. (2020) · Glia · doi:10.1002/glia.23915 · Cited by 22
Self-citationRǎdulescu, A., Todd, G. C., Williams, C., Bennink, B., Lemus, A. A., Chesbro, H. E., Bourgeois, J. R., Kopec, A. M., Zuloaga, D. G., & Scimemi, A. (2022) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1009845 · Cited by 24
The role of excitatory amino acid transporter 2 (EAAT2) in epilepsy and other neurological disorders
Alijanpour, S., Miryounesi, M., & Ghafouri‐Fard, S. (2022) · Metabolic Brain Disease · doi:10.1007/s11011-022-01091-5 · Cited by 20
Jiao, X., Wan, J., Wu, W., Ma, L., Chen, C., Dong, W., Liu, Y., Jin, C., Sun, A., Zhou, Y. X., et al. (2024) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.70024 · Cited by 17
Oudart, M., Avila‐Gutierrez, K., Moch, C., Dossi, E., Milior, G., Boulay, A.-C., Gaudey, M., Moulard, J., Lombard, B., Loew, D., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112456 · Cited by 18
Astrocyte-neuron crosstalk in neurodevelopmental disorders
Sejourne, G. M., & Eroğlu, Ç. (2024) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2024.102925 · Cited by 20
Ren, B., Burkovetskaya, M., Jung, Y., Bergdolt, L., Totusek, S., Martinez‐Cerdeno, V., Stauch, K., Korade, Z., & Dunaevsky, A. (2023) · Glia · doi:10.1002/glia.24331 · Cited by 18
Freel, B. A., Kelvington, B. A., Sengupta, S., Mukherjee, M., & Francis, K. R. (2022) · Disease Models & Mechanisms · doi:10.1242/dmm.049843 · Cited by 17
“…activation, aberrant calcium signaling, disturbed glutamate uptake, downstream impacts on neurite outgrowth and synaptogenesis, and APOE secretion (Dong et al., 2018; Higashimori et al., 2016; Jacobs and Doering, 2010; Laurence and Fatemi, 2005; Trachtenberg et al., 2012; Vargas et al., 2005).”
FMRP ribonucleoprotein complexes and RNA homeostasis
Suardi, G. A. M., & Haddad, L. A. (2020) · Advances in genetics · doi:10.1016/bs.adgen.2020.01.001 · Cited by 18
Differential Proliferation and Maturation of Subcortical Astrocytes During Postnatal Development
Shoneye, T., Orrego, A. T., Jarvis, R., Men, Y., Chiang, M. S. R., & Yang, Y. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00435 · Cited by 16
Self-citationNeuroimmune mechanisms in autism etiology - untangling a complex problem using human cellular models
Vacharasin, J. M., Ward, J. A., McCord, M. M., Cox, K., Imitola, J., & Lizarraga, S. B. (2024) · Oxford Open Neuroscience · doi:10.1093/oons/kvae003 · Cited by 17
Reynolds, K. E., Krasovska, V., & Scott, A. L. M. (2021) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2021.577745 · Cited by 14
Non-coding RNA in Fragile X Syndrome and Converging Mechanisms Shared by Related Disorders
Zhou, Y., Hu, Y., Sun, Q., & Xie, N. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00139 · Cited by 13
Spoto, G., Rosa, G. D., & Nicotera, A. G. (2024) · Journal of Personalized Medicine · doi:10.3390/jpm14020156 · Cited by 12
Marco, B. D., Dell’Albani, P., D’Antoni, S., Spatuzza, M., Bonaccorso, C. M., Musumeci, S. A., Drago, F., Bardoni, B., & Catania, M. V. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105338 · Cited by 12
D’Antoni, S., Spatuzza, M., Bonaccorso, C. M., & Catania, M. V. (2024) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2024.105731 · Cited by 11
Chemogenetic manipulation of astrocyte activity at the synapse— a gateway to manage brain disease
Pereira, M. J., Ayana, R., Holt, M. G., & Arckens, L. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1193130 · Cited by 10
Hooshmandi, M., Ho-Tieng, D., Lister, K. C., Cai, W., Wong, C., Brown, N., Fan, J., Hovhannisyan, V., Uttam, S., Prager‐Khoutorsky, M., et al. (2025) · Molecular Autism · doi:10.1186/s13229-025-00648-2 · Cited by 9
Involvement of brain metabolism in neurodevelopmental disorders
Kotchetkov, P., Blakeley, N., & Lacoste, B. (2023) · International review of neurobiology · doi:10.1016/bs.irn.2023.08.004 · Cited by 9
Astrocytes in fragile X syndrome
Talvio, K., & Castrén, M. L. (2024) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2023.1322541 · Cited by 8
Jäntti, H., Michels, S., Cherubini, E., Giniatullin, R. A., & Malm, T. (2026) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2026.106275 · Cited by 9
FMR1 loss in a human stem cell model reveals early changes to intrinsic membrane excitability
Susco, S. G., Arias-García, M. A., López-Huerta, V. G., Beccard, A., Bara, A. M., Moffitt, J., Korn, J. A., Fu, Z., & Barrett, L. E. (2020) · Developmental Biology · doi:10.1016/j.ydbio.2020.09.012 · Cited by 9
Bland, K. M., Aharon, A., Widener, E. L., Song, M., Casey, Z. O., Zuo, Y., & Vidal, G. S. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105253 · Cited by 8
The role of glia in the dysregulation of neuronal spinogenesis in Ube3a-dependent ASD
Gardner, Z., Holbrook, O., Tian, Y., Odamah, K. E., & Man, H. (2024) · Experimental Neurology · doi:10.1016/j.expneurol.2024.114756 · Cited by 7
Men, Y., Higashimori, H., Reynolds, K., Tu, L., Jarvis, R., & Yang, Y. (2022) · The Journal of Neuroscience · doi:10.1523/jneurosci.0274-22.2022 · Cited by 7
Self-citationReynolds, K. E., Huang, E., Sabbineni, M., Wiseman, E., Murtaza, N., Ahuja, D., Napier, M., Murphy, K. M., Singh, K. K., & Scott, A. L. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04181-w · Cited by 6
Neuroglia in autism spectrum disorders
Heine, V. M., & Dooves, S. (2025) · Handbook of clinical neurology · doi:10.1016/b978-0-443-19102-2.00006-5 · Cited by 6
Avraham, O., Deng, P., Maschi, D., Klyachko, V. A., & Cavalli, V. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2021.796070 · Cited by 5
Fan, Q., Zhang, X., Wang, Y., & Wang, X. (2022) · Journal of Visualized Experiments · doi:10.3791/64187 · Cited by 6
Activity of Human-Specific Interlaminar Astrocytes in a Chimeric Mouse Model of Fragile X Syndrome
Anding, A., Ren, B., Padmashri, R., Burkovetskaya, M. E., & Dunaevsky, A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26136510 · Cited by 5
Astrocytic GABA controls fidelity of temporal cortical processing in Fragile X Syndrome
Wagner, V. A., Thapa, R., Norman, A. O., Varallo, A., Wimberly, J., Rais, M., Gerasymchuk, D., Piepponen, P. T., Razak, K. A., Castrén, M. L., et al. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.107233 · Cited by 8
Glial-mediated dysregulation of neurodevelopment in Fragile X Syndrome
Napier, M., Reynolds, K. E., & Scott, A. L. (2023) · International review of neurobiology · doi:10.1016/bs.irn.2023.08.005 · Cited by 6
FMRP-related retinal phenotypes: Evidence of glutamate-glutamine metabolic cycle impairment
Ardourel, M., Pâris, A., Felgerolle, C., Lesne, F., Ranchon‐Cole, I., Briault, S., & Perche, O. (2022) · Experimental Eye Research · doi:10.1016/j.exer.2022.109238 · Cited by 4
Bergdolt, L., Anding, A., Alshaqi, O., Arbabi, Z., Douchey, M., Eldridge, E., Hoffman, K., Reid, A., Sapkota, K., Monaghan, D. T., et al. (2026) · Neurobiology of Disease · doi:10.1016/j.nbd.2026.107355 · Cited by 3
Dysregulated Purinergic Signalling in Fragile X Syndrome Cortical Astrocytes
Reynolds, K. E., Napier, M., Fei, F., Green, K. M. J., & Scott, A. L. M. (2024) · NeuroMolecular Medicine · doi:10.1007/s12017-024-08802-4 · Cited by 3
Min, R., Qin, Y., Kerst, S., Saiepour, M. H., van Lier, M., & Levelt, C. N. (2024) · iScience · doi:10.1016/j.isci.2024.111410 · Cited by 4
FMR1: A Neurodevelopmental Factor Regulating Cell Metabolism in the Tumor Microenvironment
Zhou, R., Lin, H., Dou, X., Zeng, B., Zhao, X., Ma, L., Diarra, D., Liu, B., Deng, W., & Wu, T. (2025) · Biomolecules · doi:10.3390/biom15060779 · Cited by 4
Zhao, X., & Bhattacharyya, A. (2020) · Advances in neurobiology · doi:10.1007/978-3-030-45493-7_2 · Cited by 3
The utilization of non-human primates in the investigation of autism spectrum disorder
Zhang, L., & Wang, J. (2025) · Brain Research · doi:10.1016/j.brainres.2025.149900 · Cited by 2
Peña-Ortiz, M. Á., Sunstrum, J. K., Ghahramani, A., McConkey, H., Dumeaux, V., Inoue, W., & Bérubé, N. G. (2025) · Glia · doi:10.1002/glia.70098 · Cited by 2
Rava, A., Feo, A., Bagnato, G., Doria, V., Pezzullo, M., Petrini, S., Buzzelli, V., Ascone, F., Trapano, M. D., Peruzzi, B., et al. (2026) · Neurobiology of Disease · doi:10.1016/j.nbd.2026.107304 · Cited by 2
Neuron-Astrocyte Interactions: A Human Perspective
Pio, T., Hill, E. J., Kebede, N., Andersen, J., & Sloan, S. A. (2024) · Advances in neurobiology · doi:10.1007/978-3-031-64839-7_4 · Cited by 2
Rais (2022) · doi:10.1101/2022.02.08.479618 · Cited by 2
Understanding pathophysiology in fragile X syndrome: a comprehensive review
Juárez, J. C. C., Gómez, A. A., Díaz, A. E. S., & Arévalo, G. S. (2024) · Neurogenetics · doi:10.1007/s10048-024-00794-4 · Cited by 1
Faust, T. E., Saito, A., Ishikawa, S., Yang, K., Xin, W., Namkung, H., Agarwal, A., Ramos, A., Lee, B. J., Hayes, L. N., et al. (2026) · Science Advances · doi:10.1126/sciadv.aef6777 · Cited by 4
Muzychenko, P., Minchenko, Z., Havrylenko, T., Cherniak, V., Demidov, S. V., Ryzhkova, N., & Pidhaina, O. A. (2021) · Zaporozhye Medical Journal · doi:10.14739/2310-1210.2021.4.204886 · Cited by 1
Sakers, K., Liu, Y., Llaci, L., Vasek, M. J., Rieger, M. A., Brophy, S., Tycksen, E., Lewis, R. M., Maloney, S. E., & Dougherty, J. D. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.03.13.991224 · Cited by 1
Collins, S. M. (2018) · Illinois Digital Environment for Access to Learning and Scholarship (University of Illinois at Urbana-Champaign)
Advances in the understanding of cellular pathogenesis associated with Autism Spectrum Disorder
Savory, K., & Syed, Y. A. (2019) · Journal for ReAttach Therapy and Developmental Diversities · doi:10.26407/2019jrtdd.1.21
Zhang, S., Lan, Z., Wang, Y., Kim, B., & Guo, F. (2020) · Research Square · doi:10.21203/rs.3.rs-43277/v1
Kalinowska, M., van der Lei, M. B., Kitiashvili, M., Mamcarz, M., Oliveira, M. M., Longo, F., & Klann, E. (2021) · SSRN Electronic Journal · doi:10.2139/ssrn.3956659
Neurobiology of Autism Spectrum Disorder and Intellectual Disability
Costales, J. L., Rubeis, S. D., Foss‐Feig, J. H., Hof, P. R., Buxbaum, J. D., & Kolezvon, A. (2017) · Oxford University Press eBooks · doi:10.1093/med/9780190681425.003.0063
Oudart, M., Avila‐Gutierrez, K., Moch, C., Dossi, E., Milior, G., Boulay, A.-C., Gaudey, M., Moulard, J., Lombard, B., Loew, D., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.07.16.500292
Astrocytic contribution to auditory hypersensitivity in a mouse model of fragile X syndromePreprint
Bergdolt, L., Anding, A., Alshaqi, O., Arbabi, Z., Douchey, M., Eldridge, E., Hoffman, K., Reid, A., Sapkota, K., Padmashri, R., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.02.14.638346
Deficiency of nNOS in adult‐born dentate granule cells causes epilepsy
Huang, H.-Y., Yang, Y., Wang, J., Mao, Z., Zhou, Z., Zeng, Y., Xu, H., Zhou, Y., Song, X., You, Y., et al. (2025) · Epilepsia Open · doi:10.1002/epi4.70133
Self-citationUpregulated SEMA3C in astrocytes contributes to Rett Syndrome phenotypesPreprint
Lyon, K. A., Paumier, A., Kandikonda, A., Melendez, A., & Allen, N. J. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.10.10.681027
Metadata
- Authors
- Higashimori, H., Schin, C. S., Chiang, M. S. R., Morel, L., Shoneye, T. A., Nelson, D. L., & Yang, Y.
- Affiliations
- Tufts University (US)
- Baylor College of Medicine (US)
- Venue
- Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2016-07-06
- Volume
- 36
- Issue
- 27
- Pages
- 7079-7094
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- PMC
- PMC4938857
- OpenAlex
- W2469266539
- Cited by
- 105
- References
- 54
- Citations by year
- 2026: 6 · 2025: 11 · 2024: 13 · 2023: 8 · 2022: 16 · 2021: 15 · 2020: 10 · 2019: 9 · 2018: 10 · 2017: 5 · 2016: 2
- FWCI
- 7.00
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Neuroscience (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- FRAXA Research Foundation
- Massachusetts Institute of Technology
- Autism Science Foundation
- National Institutes of Health
- Center for Neuroscience Research
- National Institute of Mental Health (R01MH099554, R01MH106490)
- National Institute of General Medical Sciences (R25GM066567)
- National Institute of Neurological Disorders and Stroke (P30NS047243)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (U54HD083092)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
- Keywords
- fragile X syndrome, FMRP, astrocytes, GLT-1, glutamate transporters, glutamate uptake, conditional knockout mice, dendritic spine morphology, cortical pyramidal neurons, protein synthesis, S6 phosphorylation, ceftriaxone, neuronal excitability, synaptic dysfunction
- MeSH terms
- Action Potentials, Age Factors, Animals, Animals, Newborn, Astrocytes, Cerebral Cortex, Disease Models, Animal, Estrogen Antagonists, Fragile X Syndrome, Gene Expression Regulation, Mice, Inbred C57BL, Nerve Tissue Proteins, Tamoxifen, Transcription Factors, Pyramidal Cells, Excitatory Amino Acid Transporter 2, Mice, Fragile X Messenger Ribonucleoprotein 1, Fragile X Mental Retardation Protein, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
